Filing Details
- Accession Number:
- 0001104659-12-014119
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-28 12:00:00
- Reporting Period:
- 2012-02-27
- Filing Date:
- 2012-02-28
- Accepted Time:
- 2012-02-28 17:21:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411158 | Anacor Pharmaceuticals Inc | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1504466 | R Kirk Maples | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | Svp, Program Management | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-27 | 3,000 | $5.90 | 30,652 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 33,652 | Direct |
Footnotes
- Includes 1,000 shares purchased on July 29, 2011 and 1,000 shares purchased on January 31, 2012, each purchased pursuant to the Issuer's ESPP.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 24, 2011.